These facts underline the significance of dUTPase inhibitory studies to better understand the role dUTPase plays in the process of cell death and characterize this enzyme as a promising additional target for anti-cancer drug development in combination therapies with thymidylate synthase inhibitors32. The gene discussed is TYMS; the disease is cancer.